GEN Exclusives

More »

GEN News Highlights

Back to Item »

BMS and Ono Expand Cancer Antibody Deal and Agree to Partner Orencia in Japan

BMS gets almost full global rights to anti-PD-1 antibody, and Ono will co-develop and co-commercialize RA drug in home territory.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?